Webcast on Demand
On demand webcast: View the webcast from the Boehringer Ingelheim press conference at the ESC 2009 in Barcelona on 30 August.
Value through Innovation17 January 2013
Stroke Prevention in Atrial Fibrillation (SPAF) News and Information
This section includes information and resources about Stroke Prevention in Atrial Fibrillation (SPAF) for journalists: Boehringer Ingelheim press releases, background information, related press kits and a collection of images and videos.
Stroke Prevention in Atrial Fibrillation (SPAF) Press Releases
| 08.11.2010 |
Dabigatran etexilate demonstrates substantial clinical benefits in atrial fibrillation patients with prior stroke or transient ischaemic attack - For Media outside the US |
|---|---|
| 27.10.2010 |
PRADAX™ (dabigatran etexilate) gains approval in Canada for stroke prevention in atrial fibrillation - For Media outside the US and Canada |
| 20.10.2010 |
US FDA Approves Pradaxa® (dabigatran etexilate) – a breakthrough treatment for stroke risk reduction in non-valvular atrial fibrillation - For non-US Healthcare Media |
| 20.09.2010 |
FDA Committee Unanimously Recommends Approval of Dabigatran Etexilate for Stroke Prevention in Atrial Fibrillation - For non-US and non-UK Healthcare Media only |
| 30.08.2010 |
A new era for patients with atrial fibrillation - Dabigatran etexilate at the forefront - For non-US Heathcare Media and Medical Media only |
SPAF Related News Room
SPAF Related Documents
Videos
-
-
Prof. Gregory Lip
- Watch the video(QT)
-
-
-
-
-
-
-
-
-
-
-
